Stephen Crosswell
Baker McKenzie (Hong Kong)
Lawyer (Partner)
Highly acclaimed and Band 1 ranked Leading Antitrust Lawyer, Stephen Crosswell is the current Chair of Baker McKenzie’s Asia-Pacific Antitrust & Competition Group. He is also that Head of our Greater China Antitrust & Competition team. Clients laude Stephen for his "years of experience working on competition matters". He is described as a "vital resource for clients seeking to navigate the nuances not only of the new local competition law regime in Hong Kong but also across other Asian jurisdictions – including China". Stephen has been granted "Solicitor Advocate" status before the Hong Kong Courts, meaning that he is uniquely placed as a specialist competition advocate in Hong Kong, having rights of audience in the Competition Tribunal and appeal courts. He is representing one of the parties to the first enforcement action that has been taken in Hong Kong’s Competition Tribunal.
Distinctions
Winner, 2021 Antitrust Writing Awards: Business, Private Enforcement
Nominee, 2020 Antitrust Writing Awards: Business, Asian Antitrust
Winner, 2019 Antitrust Writing Awards: Academic, Cross-Border Issues
Nominee, 2018 Antitrust Writing Awards: Business, Asian Antitrust
Nominee, 2017 Antitrust Writing Awards: Business, Asian Antitrust
Linked authors
Mehdi Achachera
Baker Mckenzie (Paris)
Junya Ae
Baker McKenzie (Tokyo)
Ben Allgrove
Baker McKenzie (London)
Luis Francisco Amado Cordova
Baker Mckenzie (Mexico)
Gan Andre
Wong Partners (Baker McKenzie Kuala Lumpur)
13537 | Conferences
Articles
604 Bulletin
130
The China’s State Administration for Market Regulation ("SAMR")’s local branch in Zhejiang Province on 27 September 2021 announced a fine of USD 45.62 million on Bull Group for resale price maintenance ("RPM"). The SAMR has historically taken a tough stance on RPM and its recent imposition of (...)
42
The bulletin sets out the authority’s potential competition concerns regarding admission and expulsion rules of Hong Kong trade, sporting, professional and industry bodies (i.e. "trade associations"), based on its investigatory work. The Hong Kong Competition Commission ("HKCC") has previously (...)
227
On 9 April 2020, China’s State Administration for Market Regulation (SAMR) fined three domestic pharmaceutical companies Shandong Kanghui Medicine Company Limited ("Kanghui"), Weifang Puyunhui Pharmaceutical Company Limited ("Puyunhui") and Weifang Taiyangshen Company Limited Pharmaceutical (...)
20
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Since September 2018, the State Administration for Market Regulation ("SAMR"), the consolidated Chinese competition authority, has strengthened its enforcement of (...)
185
On 27 April 2017, Hong Kong’s High Court rejected allegations by travel agency, Loyal Profit International Development that certain directives issued by the Travel Industry Council (TIC) were anti-competitive, and refused to rule on alleged violations of competition law. Loyal Profit alleged (...)
